Sensus Healthcare Stock Quote SRTS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

6.00

Bid

6.10

Ask

6.30

Volume

382,192

5.8301 Day's Range 6.55

1.79 52 Week Range 6.55

Market Cap

97.311M

Previous Close

6.42

Open

6.43

Last Trade

6.1

Last Trade Time

Financial Volume

$ 2,404,620

VWAP

6.2917

Average Volume (3m)

531,242

Shares Outstanding

16,382,404

Dividend Yield

PE Ratio

200.68

Earnings Per Share (EPS)

0.03

Revenue

24.41M

Net Profit

485k

Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service pr... Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated primarily from customers in the United States. Show more

Sector

Surgical,med Instr,apparatus

Industry

Surgical,med Instr,apparatus

Website

www.sensushealthcare.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Sensus Healthcare Inc is listed in the Surgical,med Instr,apparatus sector of the NASDAQ with ticker SRTS. The last closing price for Sensus Healthcare was $6.42. Over the last year, Sensus Healthcare shares have traded in a share price range of $ 1.79 to $ 6.55.

Sensus Healthcare currently has 16,382,404 shares outstanding. The market capitalization of Sensus Healthcare is $97.31 million. Sensus Healthcare has a price to earnings ratio (PE ratio) of 200.68.

Overall Flow

Bullish

Net Premium

27k

Calls / Puts

100.00%

Buys / Sells

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Sensus Healthcare Reports First Quarter 2024 Financial Results With Revenues up More than Three-fold

Revenues of $10.7 million, compared with $3.4 million in the prior-year quarter; Adjusted EBITDA (a non-GAAP measure) of $3.0 million, compared with negative $2.7 million in the prior-year...

Largest Veterinary Emergency Hospital in Tel Aviv Acquires Sensus Healthcare’s SRT-100™ to Provide Gentler Radiotherapy to Treat Tumors in Dogs and Cats

First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing...

Sensus Healthcare Announces Sale of First SRT-100 Vision™ System to Asia

Reminder: First Quarter 2024 Financial Results Reporting and Conference Call on May 9, 2024 BOCA RATON, Fla, May 06, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical...

Sensus Healthcare Issues Reminder That its First Quarter 2024 Financial Results and Business Update Conference Call Will be Held on Thursday, May 9, 2024

BOCA RATON, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both...

Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024

BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both...

Sensus Healthcare to Participate in the 36th Annual Roth Conference

Management will discuss its new “Fair Deal Agreement” for its SRT-100 Vision™ IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th BOCA RATON, Fla., March 14, 2024...

Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting

New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers Active traffic at the Company’s booth generated a record-high...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	1.18	24.4813278008	4.82	6.55	4.37	4795619	5.35276187	CS
4	2.75	84.6153846154	3.25	6.55	3.16	1317402	5.20635787	CS
12	1.23	25.786163522	4.77	6.55	2.91	531242	4.97992388	CS
26	3.94	191.262135922	2.06	6.55	2.02	320580	4.65315249	CS
52	3.07	104.778156997	2.93	6.55	1.79	211803	4.21455936	CS
156	2.76	85.1851851852	3.24	15.25	1.79	235520	7.30469272	CS
260	0.65	12.1495327103	5.35	15.25	1.7603	173889	6.72220517	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DUOFangDD Network Group Ltd	$ 1.65 (313.74%)	104.68M
FLJFLJ Group Limited	$ 1.54 (220.90%)	57.28M
JFBRJeffs Brands Ltd	$ 0.6276 (102.45%)	37.97M
IPWiPower Inc	$ 2.89 (97.95%)	11.05M
CETXCemtrex Inc	$ 0.4851 (48.58%)	21.23M
BSFCBlue Star Foods Corporation	$ 0.0757 (-45.26%)	60.09M
SINTSiNtx Technologies Inc	$ 0.084602 (-39.57%)	156.35M
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
HSCSHeart Test Laboratories Inc	$ 7.00 (-38.11%)	348.9k
AMPGAmplitech Group Inc	$ 1.46 (-32.09%)	613.31k
CRKNCrown Electrokinetics Corporation	$ 0.171 (-28.75%)	1.74B
FFIEFaraday Future Intelligent Electric Inc	$ 1.0189 (-38.25%)	1.31B
GWAVGreenwave Technology Solutions Inc	$ 0.1541 (4.05%)	1.16B
AKANAkanda Corporation	$ 0.1726 (30.26%)	566.51M
PEGYPineapple Energy Inc	$ 0.1053 (-28.85%)	219.25M